Financials
- Market Capitalization 640.45 B
- Employee 141 K
- Founded N/A
- CEO Kenji Tanaka
- Website www.jnj.com
- Headquarter New Jersey, United States
- FIGI BBG000BMHYD1
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 11 | LLY Eli Lilly and Company Common Stock | 1175.12 USD | -1.18% | -4.52% | -3.30% | +60.47% | 1.11 T USD | ||
| 23 | ABBV AbbVie Inc. Common Stock | 258.02 USD | -1.82% | -1.14% | -2.36% | +24.10% | 455.95 B USD | ||
| 34 | MRK Merck & Company, Inc. Common Stock | 149.54 USD | -2.32% | +0.25% | +12.83% | +79.26% | 368.94 B USD | ||
| 46 | NVS Novartis AG | 154.65 USD | -1.84% | -0.97% | -2.86% | +22.54% | 295.10 B USD |
Frequently asked questions about Johnson & Johnson
What is the Johnson & Johnson stock price today?
The current price of Johnson & Johnson (JNJ) is 265.76. Over the past 24 hours, the stock has changed by -1.59%. Follow the JNJ chart for real-time price dynamics.
What is the stock ticker of Johnson & Johnson?
Johnson & Johnson trades under the ticker JNJ. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Johnson & Johnson stock going up?
JNJ has changed by -0.87% over the last week, -1.00% over the last month, and +51.16% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Johnson & Johnson?
Johnson & Johnson currently has a market capitalization of 640.45 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does Johnson & Johnson release financial reports?
Yes. You can track Johnson & Johnson financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were Johnson & Johnson earnings last quarter?
Last quarter, Johnson & Johnson reported earnings of 2.12 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Johnson & Johnson revenue for the last quarter?
Johnson & Johnson reported quarterly revenue of 24.56 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Johnson & Johnson net income for the last quarter?
Johnson & Johnson reported net income of 5.12 B for the last quarter. The previous quarter showed 5.15 B, which means net income changed by -0.70%.
Does Johnson & Johnson pay dividends?
Johnson & Johnson paid a dividend per share of 5.14. The current dividend yield is 2.48%. Dividend data can help income-focused investors evaluate the stock.
Is Johnson & Johnson a good dividend stock?
Johnson & Johnson currently has a dividend yield of 2.48%. Previously, the dividend yield was 4.82%, compared with 3.51% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.
How many employees does Johnson & Johnson have?
As of the latest available data, Johnson & Johnson has 140.8 K employees. Workforce size can provide additional context about the company's scale and operations.
What is Johnson & Johnson EBITDA?
Johnson & Johnson EBITDA is 2.69 B, and its EBITDA margin is 10.98%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Johnson & Johnson stock?
You can buy Johnson & Johnson (JNJ) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Johnson & Johnson stock?
Investing in Johnson & Johnson requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the JNJ chart and related analysis on metatrader.com as part of your research.